HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Martínez-Torrecuadrada, J. L. Articles by Casal, J. I. Search for Related Content PubMed PubMed Citation Articles by Martínez-Torrecuadrada, J. L. Articles by Casal, J. I. Agricola Articles by Martínez-Torrecuadrada, J. L. Articles by Casal, J. I.

Definition of neutralizing sites on African horse sickness virus serotype 4 VP2 at the level of peptides

INGENASA, Hnos García Noblejas 41, 28037 Madrid, Spain¹
Institute for Animal Science and Health (ID-Lelystad), Department of Molecular Recognition, Edelhertweg 15, 8219 PH Lelystad, The Netherlands²

Author for correspondence: Jorge Martínez-Torrecuadrada. Fax +34 91 4087598. e-mail jmartinez{at}ingenasa.es

The antigenic structure of African horse sickness virus (AHSV) serotype 4 capsid protein VP2 has been determined at the peptide level by PEPSCAN analysis in combination with a large collection of polyclonal antisera and monoclonal antibodies. VP2, the determinant for the virus serotype and an important target in virus neutralization, was found to contain 15 antigenic sites. A major antigenic region containing 12 of the 15 sites was identified in the region between residues 223 and 400. A second domain between residues 568 and 681 contained the three remaining sites. These sites were used for the synthesis of peptides, which were later tested in rabbits. Of the 15 synthetic peptides, three were able to induce neutralizing antibodies for AHSV-4, defining two neutralizing epitopes, ‘a’ and ‘b’, between residues 321 and 339, and 377 and 400, respectively. A combination of peptides representing both sites induced a more effective neutralizing response. Still, the relatively low neutralization titres make the possibility of producing a synthetic vaccine for AHSV unlikely. The complex protein–protein interaction of the outer shell of the viral capsid would probably require the presence of either synthetic peptides in the correct conformation or peptide segments from the different proteins VP2, VP5 and VP7.

This article has been cited by other articles:

				A. C. Potgieter, M. Cloete, P. J. Pretorius, and A. A. van Dijk A first full outer capsid protein sequence data-set in the Orbivirus genus (family Reoviridae): cloning, sequencing, expression and analysis of a complete set of full-length outer capsid VP2 genes of the nine African horsesickness virus serotypes J. Gen. Virol., May 1, 2003; 84(5): 1317 - 1326. [Abstract] [Full Text] [PDF]